1) CDCManagement of patients with suspected viral hemorrhagic fever. MMWR 198837 (No.S-3)1-15. 2) CDCUpdatemanagement of patients with suspected viral hemorrhagic fever-united States. MMWR 199544 (No.25)475-479. 3) Breuer J, Jeffries DJControl of viral infections in hospitals. J Hosp Infect 199016191-221. 4) Coates D, Hutchinson DNHow to produce a hospital disinfection policy. J Hosp Infect 1994 2657-68 5) Rutala WAAPIC guideline for selection and use of disinfectants. Am J Infect Control 1996 24313-342. 6) Ayliffe GAJ, Coates D, Hoffeman PNChemical Disinfection in Hospitals, Public Health Laboratory Service, London, 1993. 7) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JDControl of Hospital Infection, Chapman & Hall Medical, London, 1993. 8) Reynolds JEF (ed.)martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press, London, 1996. 9) Fisher-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JBCrimean Congo-Haemorrhagic Fever treated with oral ribavirin. Lancet 1995346472-475. 10) 1998. 11) 1994. 12) Garner JSGuideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 19961753-80. 13) Fisher-Hoch SP, Price ME, Craven RB, et alsafe intensive-care management of a severe case of Lassa Fever with simple barrier nursing techniques. Lancet 1985ii1227-1229. 14) Tyler R, Ayliffe GAJ, Bradley CVirucidal activity of disinfectants with sludies with the poliovirus. J Hosp Infect 199015339-345. 15) Gardner JF, Peel MMIntroduction to Sterilization, Disinfection and Infection Control. 2nd ed. Churchill Livingstone, Melbourne, 1991. 16) Ayliffe GAJ, Coates D, Hoffman PNChemical Disinfection in Hospitals. Public Health Laboratory Service, London, 1993. 17) Ayliffe GAJ, Lowbury EJL, Geddes AM, Williams JDControl of Hospital Infection. Chapman & Hall Medical, London, 1993. 18) Ayliffe GAJ, Collins BJ, Taylor LJ Hospital-acquired Infection. 2nd ed. Butterworth Heinemann, Oxford, 1993. 19) American Medical AssociationDrug Evaluations Annual 1995, W.B. Saunders Company, Philadelphia, 1995. 20) Reynolds JEF (ed.)martindale The Extra Pharmacopoeia. 31th ed. The Pharmaceutical Press, London, 1996. 21) Oie S, Kamiya A, Tomita M, et alefficacy of disinfectants and heat against Escherichia coli O157H7. Microbios 1999987-14. 22) Sagripanti J, Eklund CA, Trost PA, Jinneman KC, Abeyta C, Kaysner CA, et alcomparative sensitivity of 13 species of pathogenic bacteria to seven chemical germicides. Am J Infect Control 199725335-339. 23) DuPont Hl, Hornick RB, Snyder MJ, Libonati JP, Formal SB, Gangarosa EJImmunity in shigellosis.. protection induced by oral live vaccine or primary infection. J Infect Dis 1972

12512-16. 24) Keene We, McAnulty JM, Hoesly FC, Williams LP, Hedberg K, Oxman GL, et ala Swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157H7 and Shigella sonnei. N Engl J Med 1994331579-584. 25) Hornick RB, Greisman SE, Woodward TE, Dupont HL, Dawkins AT, Snyder MJTyphoid feverpathogenesis and immunologic control. N Engl J Med 1970283686-691. 26) Thraenhart Q, Jursch CMeasures for disinfection and control of viral hepatitis. InBlock SS, ed. Disinfection, Sterilization and Preservation, 8th ed. PhiladelphiaLippincott Williams & Wilkins 2001585-615.